However all these drugs used now have great toxic side effect, bad tolerance so it's hard to reach optimaltherapeuticdosage, and what's more the response rate is low.
The Ad5-TRAIL gene therapy for prostate cancer research trial is a Phase I study designed to test the optimaldosage at which the therapeutic agent can safely be given to patients.